Clinical Trial Results:
Randomised, Controlled, Open-Label, Multi-Centre Comparison of Thalidomide Versus High-Dose Dexamethasone for the Treatment of Relapsed Refractory Multiple Myeloma
Summary
|
|
EudraCT number |
2005-004937-16 |
Trial protocol |
DE HU CZ GB SK PT IT |
Global completion date |
28 Jan 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 May 2017
|
First version publication date |
18 May 2017
|
Other versions |
|
Summary report(s) |
THA-PH-INT-2005-CL-001 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.